Medicine & Life Sciences
Taiwan
100%
Colorectal Neoplasms
99%
Hepatocellular Carcinoma
98%
Helicobacter pylori
96%
Chronic Hepatitis B
72%
Neoplasms
71%
Stomach
67%
Chronic Hepatitis C
56%
Stomach Neoplasms
50%
Therapeutics
48%
Apoptosis
44%
Liver Cirrhosis
42%
Liver
35%
Carcinoma
34%
Non-alcoholic Fatty Liver Disease
33%
Colonoscopy
32%
Interferons
32%
Proteins
31%
Hepacivirus
30%
Colonic Neoplasms
28%
Fatty Liver
28%
Adenocarcinoma
27%
Fibrosis
27%
Duodenal Ulcer
26%
Confidence Intervals
26%
cytolethal distending toxin
25%
Hepatitis B virus
25%
Pancreatic Neoplasms
25%
Helicobacter Infections
25%
15,16-dihydrotanshinone I
24%
Endoscopic Mucosal Resection
24%
Serum
24%
Intussusception
24%
Ulcer
23%
Odds Ratio
23%
Sorafenib
23%
Liver Diseases
22%
Antiviral Agents
22%
Neoplastic Stem Cells
21%
Population
21%
ErbB Receptors
21%
velpatasvir
21%
Recurrence
20%
Raman Spectrum Analysis
20%
Systematic Reviews
20%
lycium barbarum polysaccharide
20%
Neoplasm Metastasis
19%
evodiamine
19%
Survival
19%
Chromosome Segregation
19%
Catenins
19%
Inflammation
19%
Cetuximab
19%
Drug Therapy
19%
Hepatitis
19%
Alanine Transaminase
19%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
19%
Hepatitis B
19%
Cohort Studies
19%
Peptic Ulcer
18%
Pylorus
18%
Metaplasia
18%
Cellular Apoptosis Susceptibility Protein
18%
Radiofrequency Ablation
18%
Sofosbuvir
18%
Liver Neoplasms
17%
Mucous Membrane
17%
Meta-Analysis
17%
Gastritis
17%
Lipopolysaccharides
17%
Growth
17%
Safety
17%
glucose-regulated proteins
17%
lipoteichoic acid
16%
Pancreatitis
16%
ovatodiolide
16%
Gastrointestinal Diseases
16%
Sustained Virologic Response
16%
Heme Oxygenase-1
16%
Fluorouracil
16%
Cell Proliferation
16%
Digestive System Endoscopy
16%
Evodia
16%
Cholesterol
16%
Biomarkers
15%
Campylobacter jejuni
15%
Alcoholic Liver Diseases
15%
Reactive Oxygen Species
15%
Randomized Controlled Trials
15%
Extracellular Signal-Regulated MAP Kinases
15%
Propensity Score
15%
Cell Line
14%
Iron
14%
Gastrointestinal Microbiome
14%
Phosphotransferases
14%
Hepatitis B Surface Antigens
14%
Nanoparticles
14%
Prostatic Neoplasms
14%
Nitric Oxide
14%
entecavir
14%